Your browser doesn't support javascript.
loading
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Moschos, Stergios J; Eroglu, Zeynep; Khushalani, Nikhil I; Kendra, Kari L; Ansstas, George; In, Gino K; Wang, Peng; Liu, Glenn; Collichio, Frances A; Googe, Paul B; Carson, Craig C; McKinnon, Karen; Wang, Hsing-Hui; Nikolaishvilli-Feinberg, Nana; Ivanova, Anastasia; Arrowood, Christy C; Garrett-Mead, Nancy; Conway, Kathleen C; Edmiston, Sharon N; Ollila, David W; Serody, Jonathan S; Thomas, Nancy E; Ivy, S Percy; Agrawal, Lokesh; Dees, Elizabeth C; Abbruzzese, James L.
Afiliação
  • Moschos SJ; Department of Medicine, The University of North Carolina at Chapel Hill.
  • Eroglu Z; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Kendra KL; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Ansstas G; Department of Medicine, The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.
  • In GK; Department of Medicine, Washington University School of Medicine Siteman Cancer Center, Saint Louis, Missouri.
  • Wang P; Department of Medicine, The University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
  • Liu G; Department of Medicine, University of Kentucky Albert Chandler Medical Center, Zion, Illinois.
  • Collichio FA; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Googe PB; Department of Medicine, The University of North Carolina at Chapel Hill.
  • Carson CC; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • McKinnon K; Department of Dermatology.
  • Wang HH; Department of Dermatology.
  • Nikolaishvilli-Feinberg N; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill.
  • Ivanova A; Immunogenomics Facility, Lineberger Comprehensive Cancer Center.
  • Arrowood CC; Immunogenomics Facility, Lineberger Comprehensive Cancer Center.
  • Garrett-Mead N; The University of North Carolina Translational Pathology Laboratory.
  • Conway KC; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Edmiston SN; Department of Biostatistics, The University of North Carolina Gillings School of Global Public Health, Chapel Hill.
  • Ollila DW; Department of Medicine, Duke Cancer Institute, Durham, North Carolina.
  • Serody JS; UM1 Consortium, National Cancer Institute (NCI) Experimental Therapeutics Clinical Trials Network, Bethesda, Maryland.
  • Thomas NE; Department of Medicine, Duke Cancer Institute, Durham, North Carolina.
  • Ivy SP; UM1 Consortium, National Cancer Institute (NCI) Experimental Therapeutics Clinical Trials Network, Bethesda, Maryland.
  • Agrawal L; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Dees EC; Department of Dermatology.
  • Abbruzzese JL; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Melanoma Res ; 31(2): 162-172, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33661190
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias Cutâneas / Adenina / Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias Cutâneas / Adenina / Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article